Research ArticleAccepted Article
Disease modifying anti-rheumatic drugs, biologics and corticosteroid use in older patients with rheumatoid arthritis over 20 years
John G. Hanly and Lynn Lethbridge
The Journal of Rheumatology August 2020, jrheum.200310; DOI: https://doi.org/10.3899/jrheum.200310
John G. Hanly
Division of Rheumatology, Department of Medicine, and Department of Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada; Department of Surgery, Dalhousie University, Halifax, Nova Scotia Canada. Address Correspondence to Dr. John G. Hanly, Division of Rheumatology, Nova Scotia Rehabilitation and Arthritis Centre, 1341 Summer Street – Suite 245, Halifax, Nova Scotia, B3H 4K4. Email: john.hanly@nshealth.ca
Lynn Lethbridge
Division of Rheumatology, Department of Medicine, and Department of Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada; Department of Surgery, Dalhousie University, Halifax, Nova Scotia Canada. Address Correspondence to Dr. John G. Hanly, Division of Rheumatology, Nova Scotia Rehabilitation and Arthritis Centre, 1341 Summer Street – Suite 245, Halifax, Nova Scotia, B3H 4K4. Email: john.hanly@nshealth.ca
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Disease modifying anti-rheumatic drugs, biologics and corticosteroid use in older patients with rheumatoid arthritis over 20 years
John G. Hanly, Lynn Lethbridge
The Journal of Rheumatology Aug 2020, jrheum.200310; DOI: 10.3899/jrheum.200310